Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
13%
OVERLAP
BY WEIGHT
3
# OF OVERLAPPING
HOLDINGS
XLV
60
HOLDINGS
5%
ALSO IN PSIL
PSIL
35
HOLDINGS
23%
ALSO IN XLV
SECTOR DRIFT (XLV minus PSIL)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XLV |
Weight in PSIL |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 15.2% | 4.7% | 4.7% |
|
ABBVIE INC | 7.9% | 4.5% | 4.5% |
|
JOHNSON & JOHNSON | 10.1% | 4.3% | 4.3% |
XLV Overweight Relative to PSIL
|
ELI LILLY & CO | 10.5% |
|
JOHNSON & JOHNSON | 5.8% |
|
MERCK & CO. INC. | 5.8% |
|
UNITEDHEALTH GROUP INC | 5.5% |
|
THERMO FISHER SCIENTIFIC INC | 3.9% |
|
AMGEN INC | 3.6% |
|
ABBVIE INC | 3.4% |
|
GILEAD SCIENCES INC | 3.0% |
|
ABBOTT LABORATORIES | 2.8% |
|
PFIZER INC | 2.6% |
XLV Underweight Relative to PSIL
|
DEFINIUM THERAPEUTICS INC | -11.6% |
|
RELMADA THERAPEUTICS INC | -4.7% |
|
NEUROCRINE BIOSCIENCES INC | -4.5% |
|
NEURONETICS, INC. | -4.1% |
|
ALTO NEUROSCIENCE INC | -4.1% |
|
BRIGHT MINDS BIO | -3.7% |
 |
ALKERMES PLC | -3.4% |
|
SUPERNUS PHARMACEUTICALS INC | -3.2% |
 |
NUMINUS WELLNESS INC | -0.7% |
|
INDIA GLOBALIZATION CAPITAL, INC. | -0.5% |